Amgen’s first quarter results reflected robust demand across its portfolio, with product volumes and sales increasing in both ...

AI partners Microsoft and OpenAI’s cooling relationship cools further with Amgen’s switch from Copilot to ChatGPT.

JLL Capital Markets secured $182M in construction financing & equity for Latigo Group's 333-unit Hillcrest Apartments in ...

Talented female scientists are being pushed out of cancer research due to gender discrimination, ageism and an absence of ...

Despite investing tens of billions of dollars into OpenAI, Microsoft is still, apparently, competing with its business ...

For high-risk patients with type 2 diabetes, oral semaglutide reduced risk for major cardiovascular and ischemic limb-related ...

Artificial intelligence chatbots are fast becoming staples of modern office life, but it’s clear that not all tools are ...

What does the fracturing of vaccine advice and policy mean for the U.S. health care ecosystem? Will the potential head of the Centers for Disease Control ...

Drugs such as Ozempic (a brand name for semaglutide) are showing promise for weight loss. Another medication in the same ...

Corporates don't want Copilot Software King of the World, Microsoft is finding out the hard way that even a decades-long grip ...

A new drug, 'MariTide,' developed by Amgen, has shown significant potential in treating obesity, with trial participants losing up to 16% body weight annually.

A Fierce Pharma Marketing review of the LinkedIn and Instagram pages of the 20 largest pharmas found that, as of Thursday, ...